Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sue Klapholz is active.

Publication


Featured researches published by Sue Klapholz.


Annals of the New York Academy of Sciences | 2008

Production of Antigen-Specific Human Antibodies from Mice Engineered with Human Heavy and Light Chain YACsa

Aya Jakobovits; Larry Green; Margaret C. Hardy; Catherine E. Maynard-Currie; Hirohisa Tsuda; Donna M. Louie; Michael Mendez; Hadi Abderrahim; Masato Noguchi; Douglas H. Smith; Yongjun Zeng; Nathaniel E. David; Hitoshi Sasai; Dan Garza; Daniel G. Brenner; Joanna F. Hales; Ryan McGuinness; Daniel J. Capon; Sue Klapholz

Our paper describes the introduction of large fragments of both the human heavy and light chain Ig genes into the mouse germline to create a mouse strain capable of producing a broad repertoire of antigen-specific, fully human antibodies. The human immunoglobulin gene sequences were functional in the context of the mouse machinery for antibody recombination and expression, either in the presence or absence of functional endogenous genes. This was demonstrated by their ability to undergo diverse rearrangement, to be expressed at significant levels, and to exclude expression of mouse immunoglobulins irrespective of their copy number or site of integration. The decrease in susceptibility to influence by adjacent genomic sequences may reflect the greater size, variable gene content, or structural integrity of the human Ig YACs and/or the presence of unidentified but important regulatory elements needed for optimal expression of the human immunoglobulin genes and their correct regulation. Our results show that mouse B cells coexpressing human heavy and kappa chains, upon immunization, can produce antigen-specific, fully human antibodies. Furthermore, the human heavy and kappa chain YACs induced differentiation and maturation of the growth-arrested B-cell lineage in mice with inactivated endogenous Ig genes, leading to the production of a diverse repertoire of fully human antibodies at levels approaching those in normal serum. These results suggest the potential value of these mice as a source of fully human antibodies for human therapy. Furthermore, it is expected that such mice would lack immunological tolerance to and thus readily yield antibodies to human proteins, which may constitute an important class of targets for monoclonal antibody therapy. Our findings suggest that the introduction of even larger portions of the human heavy and light chain loci, which should be achievable with the ES cell-yeast spheroplast fusion technology described, will result in strains of mice ultimately capable of recapitulating the full antibody repertoire characteristic of the human humoral response to infection and immunization. The present and future mouse strains may prove to be valuable tools for studying the molecular mechanisms and regulatory sequences influencing the programmed assembly and expression of human antibodies in the normal immune response, as well as the abnormal response characteristic of autoimmune disease and other disorders. The strategy we have described for the introduction of large segments of the human genome into mice in conjunction with the inactivation of the corresponding mouse loci may also have broad applicability to the investigation of other complex or uncharacterized loci.


Genomics | 1995

Analysis of the structural integrity of YACs comprising human immunoglobulin genes in yeast and in embryonic stem cells

Michael Mendez; Hadi Abderrahim; Masato Noguchi; Nathaniel E. David; Margaret C. Hardy; Larry Green; Hirohisa Tsuda; Sienna Yoast; Catherine E. Maynard-Currie; Dan Garza; Robert M. Gemmill; Aya Jakobovits; Sue Klapholz

With the goal of creating a strain of mice capable of producing human antibodies, we are cloning and reconstructing the human immunoglobulin germline repertoire in yeast artificial chromosomes (YACs). We describe the identification of YACs containing variable and constant region sequences from the human heavy chain (IgH) and kappa light chain (IgK) loci and the characterization of their integrity in yeast and in mouse embryonic stem (ES) cells. The IgH locus-derived YAC contains five variable (VH) genes, the major diversity (D) gene cluster, the joining (JH) genes, the intronic enhancer (EH), and the constant region genes, mu (C mu) and delta (C delta). Two IgK locus-derived YACs each contain three variable (V kappa) genes, the joining (J kappa) region, the intronic enhancer (E kappa), the constant gene (C kappa), and the kappa deleting element (kde). The IgH YAC was unstable in yeast, generating a variety of deletion derivatives, whereas both IgK YACs were stable. YACs encoding heavy chain and kappa light chain, retrofitted with the mammalian selectable marker, hypoxanthine phosphoribosyltransferase (HPRT), were each introduced into HPRT-deficient mouse ES cells. Analysis of YAC integrity in ES cell lines revealed that the majority of DNA inserts were integrated in substantially intact form.


Genomics | 1991

Rapid screening of a YAC library by pulsed-field gel Southern blot analysis of pooled YAC clones

Michael Mendez; Sue Klapholz; Bernard H. Brownstein; Robert M. Gemmill

A new method for screening of YAC libraries is described. Individual YACs were pooled into groups of 384 clones and prepared as samples suitable for pulsed-field gel electrophoresis. A five hit human YAC library (Brownstein et al., 1989) containing approximately 60,000 clones was condensed into 150 such pools and chromosomal DNAs in each sample were separated on three pulsed field gels containing 50 samples each. Southern blots prepared from these gels were hybridized with probes of interest to identify pools containing homologous YACs. Further purification was performed using standard colony hybridization procedures. Twenty-one probes used thus far have identified 47 positive pools and corresponding YACs have been purified from 28 of these. Some significant advantages of this method include avoidance of DNA sequence analysis and primer generation prior to YAC screening and the ability to handle the entire library on three filters. The screening approach described here permits rapid isolation of YACs corresponding to unsequenced loci and will accelerate establishment of YAC contigs for large chromosomal segments.


Archive | 1996

Human antibodies derived from immunized xenomice

Raju Kucherlapati; Aya Jakobovits; Sue Klapholz; Daniel G. Brenner; Daniel J. Capon


Archive | 1995

Generation of Xenogenetic antibodies

Raju Kucherlapati; Aya Jakobovits; Sue Klapholz; Daniel G. Brenner; Daniel J. Capon


Nature | 1993

Germ-line transmission and expression of a human-derived yeast artificial chromosome

Aya Jakobovits; Amy L. Moore; Larry Green; German J. Vergara; Catherine E. Maynard-Currie; Harry A. Austin; Sue Klapholz


Archive | 1996

Human anti-IL-8 antibodies, derived from immunized xenomice

Raju Kucherlapati; Aya Jakobovits; Sue Klapholz; Daniel G. Brenner; Daniel J. Capon


Archive | 2008

TRANSGENIC MAMMAL HAVING HUMAN Ig GENE LOCI INCLUDING A PLURALITY OF VH AND Vκ REGIONS AND ANTIBODY PRODUCED THEREFROM

Larry Green; Aya Jakobovits; Sue Klapholz; Raju Kucherlapati; Michael Mendez; ラジュ クチャラパティ; スー クラフォルツ; ラリー グリーン; アヤ ジャコボビッツ; マイケル メンデス


Archive | 2005

Human antibody originated from immunized xenomouse

Daniel G. Brenner; Daniel J. Capon; Aya Jakobovits; Sue Klapholz; Raju Kucherlapati; ダニエル ジェイ. カポン; ラジュ クシェルラパティー; スー クラホルツ; アヤ ジャコボビッツ; ダニエル ジー. ブレナー


Archive | 1997

Human antibodies that bind tnf alpha

Aya Jakobovits; Raju Kucherlapati; Sue Klapholz; Michael Mendez; Larry Green

Collaboration


Dive into the Sue Klapholz's collaboration.

Top Co-Authors

Avatar

Aya Jakobovits

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Raju Kucherlapati

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Aya Jakobovits

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Raju Kucherlapati

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Robert M. Gemmill

Medical University of South Carolina

View shared research outputs
Researchain Logo
Decentralizing Knowledge